PCV32 COST ANALYSIS OF REIMBURSED SPENDING ON ACE-INHIBITORS AND SARTANS IN BULGARIA
Nov 1, 2019, 00:00
10.1016/j.jval.2019.09.757
https://www.valueinhealthjournal.com/article/S1098-3015(19)33135-3/fulltext
Title :
PCV32 COST ANALYSIS OF REIMBURSED SPENDING ON ACE-INHIBITORS AND SARTANS IN BULGARIA
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)33135-3&doi=10.1016/j.jval.2019.09.757
First page :
Section Title :
Open access? :
No
Section Order :
10662